Johan Abel Van Den Berg

Title: Johan Abel Van Den Berg: Innovator in Kluyveromyces Technology

Introduction

Johan Abel Van Den Berg is a notable inventor based in Reeuwijk, Netherlands. He has made significant contributions to the field of biotechnology, particularly through his innovative work with Kluyveromyces as a host strain for DNA expression.

Latest Patents

Van Den Berg holds a patent for "Kluyveromyces as a host strain." This patent provides Kluyveromyces hosts and DNA expression cassettes for the transcription of endogenous and/or exogenous DNA. The technology enhances the production of peptides, either by boosting the production of an endogenous product or by facilitating the production of an exogenous product. The Kluyveromyces hosts are particularly useful for the secretion of desired peptide products, utilizing signal sequences that may be native or provided from endogenous or exogenous sources, including synthetic sequences functional in Kluyveromyces. Additionally, a transformation procedure is included for efficiently transforming Kluyveromyces.

Career Highlights

Van Den Berg is associated with DSM N.V., a company known for its focus on health, nutrition, and materials. His work at DSM N.V. has allowed him to explore and develop innovative solutions in biotechnology.

Collaborations

He has collaborated with notable colleagues such as Cornelis P. Hollenberg and Krijn Rietveld, contributing to advancements in the field through shared expertise and research.

Conclusion

Johan Abel Van Den Berg's contributions to biotechnology, particularly through his patent on Kluyveromyces, highlight his role as an innovator in the industry. His work continues to influence the production of peptides and the use of Kluyveromyces in various applications.